-

Medisca Celebrates 5-Year Partnership to Increase Access to Resources for Chronic Pain Management

MONTREAL--(BUSINESS WIRE)--In 2018, Medisca, a global leader in pharmaceutical compounding and personalized medicine, partnered with the Université Laval Faculty of Medicine located in Quebec, Canada. The commitment included funding the establishment of a Chair in Educational Leadership in Chronic Pain Treatment, donating $500,000 to the initiative. Five years later, Medisca is a proud founding partner of the collaborative success of the Université Laval’s Chair in Educational Leadership in Chronic Pain Treatment-Medisca, Dr. Anne Marie Pinard, MD FRCPC, M.(Ed.), and the Quebec Pain Research Network.

Marking the success of this multi-year initiative was the development and launch of the “My Pain Management” Web Portal in March 2021 that houses over 280 validated resources for patients, caregivers, and healthcare providers. In November 2022, the foundation also launched “Programme Agir pour moi”, an 8-week self-management program for patients experiencing chronic pain, and developed over 40 continuing education trainings for healthcare providers. Both additions were implemented in alignment with the Quebec Ministry of Health and Social Services’ new Action Plan for Chronic Pain Management that launched in early 2023.

“Every week, front-line healthcare professionals call me for advice on pain management. Offering a rich portal of free, expert-validated resources for both patients and professionals is an achievement I'm very proud of, and one that will be very useful in the field," says Dr. Anne Marie Pinard, holder of the Université Laval’s Chair in Educational Leadership in Chronic Pain Treatment-Medisca. “Medisca saw the value in our mission and we are incredibly grateful for their support in funding this important initiative,” continued Dr. Pinard.

For over 30 years, Medisca has been a leader in the pharmaceutical compounding space, contributing to the evolution of personalized medicine and better patient care. “Our mission is founded on caring about people and our contribution to healthcare would not be where it is today without partnering with institutions, such as the Université Laval, that shares this common mission” said Tony Dos Santos, President and Founder of Medisca. “The work of Dr. Anne Marie Pinard and her team have created heightened awareness about personalized wellness that will change how chronic pain is managed. They have made impressive strides in the last five years to empower patients, physicians, and pharmacists through education – and we know it is only the beginning for them,” continued Dos Santos.

Medisca is proud to be a founding sponsor that supported the development of the “My Pain Management” Web Portal and looks forward to exploring future collaboration opportunities with the Université Laval and Dr. Pinard.

About Medisca

Medisca is a global corporation with locations throughout North America, Australia, and Europe, that contributes to healthcare by leveraging strong partnerships that deliver customized solutions with an unwavering commitment to quality and innovation. Backed by 30+ years and a strong foundation in pharmaceutical compounding supply, Medisca is a business-to-business company that delivers comprehensive offerings by providing value, consistency, responsiveness, and loyalty. As Partners in Wellness, Medisca offers an unfailing devotion to improving lives across a multitude of needs and people. For more information visit www.medisca.com and follow us on LinkedIn, Facebook, Twitter, and YouTube.

Contacts

Medisca Communications
marketing@medisca.com
1-800-665-6334

Medisca


Release Versions

Contacts

Medisca Communications
marketing@medisca.com
1-800-665-6334

Social Media Profiles
More News From Medisca

Medisca and EUROAPI Form Strategic Partnership to Strengthen API Access for Pharmaceutical Compounding

MONTREAL--(BUSINESS WIRE)--Medisca and EUROAPI have formed a strategic partnership focused on expanding API access for pharmaceutical compounding, creating differentiated access in North America and establishing a broader framework for international growth and peptide collaboration. For more than three decades, Medisca has built its business around the evolving needs of pharmaceutical compounders. That starts with the products it chooses to bring to market but extends much further to the manufa...

Medisca Launches Global Peptide Division

MONTREAL--(BUSINESS WIRE)--Medisca today announced the launch of Medisca Peptides, a dedicated global division focused on expanding access to API-grade peptides and building an integrated peptide platform for pharmaceutical and personalized medicine markets worldwide. As the peptide landscape evolves, Medisca is proactively building the capabilities and infrastructure needed to support API-grade peptides within applicable regulatory frameworks. The launch represents a significant long-term comm...

Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos

MONTREAL--(BUSINESS WIRE)--For more than 35 years, Dos Santos has helped shape Medisca into a global leader in pharmaceutical compounding. As Chief Executive Officer, he will lead the company's long-term strategy, with a focus on expanding Medisca's global reach, investing in new areas of growth, strengthening strategic partnerships, and continuing to advance the products, services, education, and expertise that healthcare professionals rely on every day. "When I founded Medisca, my vision was...
Back to Newsroom